Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alfa Sensitivity in HIV/HCV Coinfected Persons
NCT01285050Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir, emtricitabine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Johns Hopkins University. Started Jan 2011; status: completed.
02
Drugs
raltegraviremtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01285050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285050.